RxDoctor Payments Data

William Gruzensky, MD

Ophthalmology · Anchorage, AKNPI 1992812234

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Alcon at 30.1% of the total. Reporting peaked in 2019 at $219 and has fallen 91.9% since, to $18 in 2024. That places this record below the midpoint for ophthalmology clinicians in AK, where the typical reported total is $803.

$299in general payments, 2019–2025

Across 8 payments — averaging $37.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$90
  • Johnson & Johnson Surgical Vision, Inc.$74
  • AbbVie$62
  • Ivantis, Inc$54
  • Rayner Intraocular Lenses Limited$18

What the payments were for

  • Food & beverage$299100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$299 in reported general payments places this provider in the 30th percentile of 30 ophthalmology providers in Alaska.

See all ophthalmology providers in Alaska

Medicare billing

Part B allowed, 2024
$490,117
Medicare patients
573
Services billed
2,071

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →